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Imaging chromatin dynamics is crucial to understand genome organization and its role in
transcriptional regulation. Recently, the RNA-guidable feature of CRISPR-Cas9 has been
utilized for imaging of chromatin within live cells. However, these methods are mostly
applicable to highly repetitive regions, whereas imaging regions with low or no repeats
remains as a challenge. To address this challenge, we design single-guide RNAs (sgRNAs)
integrated with up to 16 MS2 binding motifs to enable robust fluorescent signal amplification.
These engineered sgRNAs enable multicolour labelling of low-repeat-containing regions using
a single sgRNA and of non-repetitive regions with as few as four unique sgRNAs. We achieve
tracking of native chromatin loci throughout the cell cycle and determine differential
positioning of transcriptionally active and inactive regions in the nucleus. These results
demonstrate the feasibility of our approach to monitor the position and dynamics of both
repetitive and non-repetitive genomic regions in live cells.
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T
he spatiotemporal organization of chromatin structure
plays a critical role in regulating lineage-specific
gene expression during cellular differentiation and
embryonic development1. Global three-dimensional (3D)
genome organization and relative gene positioning have been
studied primarily using genome-wide technologies, such as
chromosome conformation capturing assays1. These methods
have proven instrumental in identifying long-range intra-
genomic interactions and cell type-specific global chromatin
states1. In addition, fluorescent in situ hybridization (FISH)2–4
has been used to determine the precise nuclear positions of
specific genetic loci in fixed cells. To study chromatin dynamics in
living cells, zinc fingers (ZNF)5 and transcription activator–like
effector (TALE) proteins6 have been engineered to target
repetitive genomic regions, such as centromeres and telomeres,
and track the spatiotemporal dynamics of these regions in live
cells. Despite these advances, these approaches are difficult to
implement for imaging non-repetitive genomic loci, since they
require constructing a large array of TALEs/ZNFs proteins
targeting the same locus.
Clustered regularly interspaced palindromic repeats (CRISPR)
and CRISPR-associated proteins (Cas) serve as a simpler and
more versatile tool for targeting specific DNA sequences in the
genome7,8. In the type II CRISPR system, a Cas9 endonuclease
enzyme is targeted to a specific genomic region containing an
NGG motif (referred to as the protospacer adjacent motif, PAM)
via a 20-nucleotide complementary sgRNA sequence9,10. The
RNA-guidable nature of CRISPR-Cas9 provides greater flexibility
over TALEs/ZNFs targeting, and has been repurposed to perform
locus-specific genome editing9–17 and whole-genome knockout
screens18–20. Moreover, the catalytically inactive mutant of Cas9
(dCas9) has been used for a wide-range applications including
control of gene regulation21–24, purification of specific genomic
regions25 and whole-genome knockdown screens26.
Previous studies have used fluorescently labelled dCas9 for
targeting repetitive regions of the genome in live cells7.
This method has been extended for multiplexed targeting of
telomeres and centromeres by co-expression of several dCas9
orthologs fused to different colours of fluorescent proteins and
their cognate sgRNAs27,28. Recently, dual-colour imaging of
telomeres and centromeres using modified sgRNAs has also been
demonstrated28–31. Targeting dCas9 to a non-repetitive genomic
locus is more challenging, because fluorescence signal of a few
dCas9-sgRNA complexes at the target region is not sufficient for
detection. This bottleneck can be overcome by transfection of
cells with 26 unique sgRNAs targeting the same region7,8.
However, this approach is difficult to implement for biological
applications due to the challenges in the delivery of dozens
sgRNAs into cells and increase in off-target sites by the large
number of sgRNAs.
Here we developed an efficient and robust CRISPR-Cas9-based
approach to simultaneously image multiple genomic loci in live
cells. This method relies on re-engineering an sgRNA containing
up to 16 MS2 motifs that bind to the bacteriophage MS2 coat
protein (MCP)32 and labelling these motifs with fluorescently
tagged MCPs. This approach enables targeting of multiple
genomic regions in human cells using a single dCas9 and a
modular set of sgRNAs. Increasing the copy number of the MS2
sites on a single sgRNA significantly improved the signal-to-noise
ratio and reduced the number of dCas9-sgRNA complexes
required for reliable detection. Using a single sgRNA, we
successfully imaged multiple genomic loci with as few as eight
tandem repeats. Non-repetitive genomic regions were detected
using as few as 4 separate sgRNAs when imaged using lattice light
sheet microscopy (LLSM). Extended sgRNAs also enabled us to
track the targeted loci over the course of the entire cell cycle, and
to distinguish the nuclear positions of various transcriptionally
active and inactive sites in the genome of live cells.
Results
Targeting low-repeat-containing loci using a single sgRNA.
We extended Cas9 cognate sgRNAs by inserting up to 14 tandem
MS2 stem-loop sequences (Fig. 1a). To test whether the extended
sgRNAs (sgRNA 14 -MS2) form a functional complex with
dCas9 while binding to MCP–YFP, we co-transfected HeLa cells
with dCas9-mCherry, MCP–YFP, and a single sgRNA 14 -MS2
targeting an 84-repeat sequence located within the MUC4 gene
(Fig. 1b). Chromatin immunoprecipitation and quantitative PCR
(ChIP–qPCR) assays verified that both dCas9 and MCP were
substantially enriched at the MUC4 site (Fig. 1c,d). Notably, the
enrichment levels were comparable to that of conventional
sgRNAs, indicating that the MS2 sites introduced at the 30
terminal end of the sgRNA did not interfere with assembly of the
dCas9-sgRNA complex at the target region29. Confocal imaging
of transfected cells revealed colocalization of bright nuclear
mCherry and YFP spots (Fig. 1e), indicating that Cas9 and
sgRNA localize to the same genomic region.
Next, using a single sgRNA 14 -MS2, we attempted to target
genomic regions containing few repeats33. We computationally
scanned the genome for 20-nucleotide sequences that can be
targeted with an sgRNA. Sequences that repeat multiple times
within a 1 kb vicinity of each other and appear only in a single
region of the whole genome were analysed further. Notably,
we identified 462,000 unique hotspots that contain 4 or more
sgRNA-targetable repeats (see Supplementary Data 1 for the
complete list of hotspots) with eight repeats on average per
hotspot (Supplementary Fig. 1). Next, we selected four unique loci
that contained 8, 15, 21 and 33 repeat sequences (locus #1, 2, 3
and 4, respectively, Fig. 1b) and separately transfected HeLa cells
with a single sgRNA complementary to each loci (Supplementary
Fig. 2). CHIP–qPCR assays confirmed the enrichment of
dCas9-sgRNA to these target sites (Fig. 1c,d). In cells that show
bright YFP and mCherry spots in the nucleus, every YFP spot
colocalized with an mCherry spot (Fig. 1e). Consistent with a
previous report7, we detected 3.4±0.3 (mean±s.e.m., Ncells¼ 57)
spots per cell corresponding to the MUC4 loci. While a similar
number of spots were observed for loci #1, #3 and #4, a higher
number of spots were detected using the sgRNA targeting locus
#2 (8.0±0.6 mean±s.e.m., Ncells¼ 106, Po0.001 for a two-tailed
t-test, Fig. 1f). Therefore, the extended sgRNA design, in
principle, enables targeting of thousands of hotspots in human
genome using a single sgRNA.
Multiplex targeting of low-repeat-containing loci. Two separate
genomic loci can be differentially labelled by targeting one site
using a conventional sgRNA that lacks the MS2 binding site and
another site using an sgRNA 14 -MS228 (Fig. 2a). As a result,
the dCas9 signal is expected to appear at both loci, whereas MCP
localizes exclusively to the locus targeted by sgRNA 14 -MS2.
While this strategy has been used for imaging highly repetitive
telomeric and centromeric sequences simultaneously28, dual-
colour imaging of low-repeat-containing loci has not been
demonstrated.
We transfected HeLa cells with plasmids of dCas9-mCherry,
MCP–YFP as well as conventional sgRNA and sgRNA 14 -MS2
targeting two low-repeat loci. As expected, in cells that show
bright YFP and mCherry spots, every YFP spot colocalized with
an mCherry spot (Fig. 2b,c), but only 62% of the mCherry spots
colocalized with YFP spots. We obtained similar results for each
combinatorial targeting of conventional and extended sgRNAs,
demonstrating that our findings are not specific to the pair of
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sgRNAs used (Fig. 2b). These results demonstrate that multi-
colour labelling of low-repeat-containing genomic loci is feasible
with dCas9 using a single extended sgRNA, thus eliminating
the need for pooling multiple sgRNAs to achieve sufficient
fluorescent signal.
To further improve the versatility of our dCas9-mediated
chromatin imaging platform, we test a variety of different sgRNA
designs (Fig. 3a). First, we utilized the high-affinity interaction
(similar to the MS2-MCP pair) between the bacteriophage
PP7 coat protein (PCP) and its RNA-binding site (PP7) by
engineering an sgRNA with 2 -PP7 sites28. Second, by inserting
MS2 binding sites into regions of the sgRNA backbone that do
not interact with Cas9, we designed sgRNA 2.0 MS2 (ref. 29)
to increase the efficiency of dCas9-mediated transactivation
complexes34. The ChIP–qPCR analysis revealed substantial
recruitment of dCas9 and MCP-PCP to the target sites with
comparable enrichment levels as conventional sgRNA (Fig. 3b,c).
For each of these sgRNA designs, we co-transfected HeLa cells
with plasmids expressing dCas9-mCherry, YFP-tagged MCP-PCP
and a single sgRNA targeting a low-repeat-containing locus. In all
cases, we observed 100% colocalization of YFP and mCherry
spots in the nucleus (Fig. 3d). The number of spots in these cells
(Fig. 3e) was significantly less than those that observed using
sgRNA 14 -MS2 (t-test, Po0.05, Fig. 1f), suggesting that these
sgRNAs are less susceptible to off-target recognition events.
Targeting of non-repetitive genomic loci. In previous studies,
imaging of non-repetitive sites has required the co-expression of
as many as 26 unique sgRNAs to achieve sufficient signal-to-noise
ratio for spot detection7. Because our extended sgRNAs recruit
a higher number of fluorescent proteins per dCas9-sgRNA
complex, we reasoned that this approach could reduce the
number of sgRNAs required to target a non-repetitive locus.
This would significantly enhance the efficiency of targeting and
imaging native chromatin loci virtually anywhere in the genome
of individual cells. To test this possibility, we first attempted to
co-transfect HeLa cells with plasmids for dCas9-mCherry and
MCP–YFP, along with 30 unique sgRNAs targeting the same
locus. However, we were not able to distinguish any cells with
bright nuclear spots, due to the low transfection efficiency
associated with introducing large numbers of plasmids into a cell.
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Figure 1 | CRISPR-mediated chromatin imaging with conventional and extended sgRNAs. (a) Schematics show the conventional sgRNA and an sgRNA
extended with 14 MS2 sites. dCas9 is fused to mCherry and MS2 binding sites are decorated with MCP–YFP. (b) sgRNA targetable tandem repeats
containing four or more unique sites with a PAM sequence (red ticks) for each chromosome of human genome. The genomic loci targeted in this work
are shown with larger symbols. (c,d) ChIP–qPCR results show relative enrichment levels of Flag-tagged dCas9 (c) and HA-Tagged MCP–YFP (d) at the
targeted loci when guided by conventional sgRNA (c) and extended sgRNA 14 -MS2 (d). N¼ 3 independent experiments. Error bars show s.e.m.
(e) Representative images show colocalization of MCP and dCas9 spots in the nucleus of HeLa cells transfected with dCas9-mCherry, MCP–YFP and a
single sgRNA 14 -MS2 targeting MUC4, locus #1 or #2. Scale bar, 3 mm. (f) The number of bright dCas9-mCherry spots detected per cell for each
targeted locus. The line and the dot within the boxplot represents the median and the mean, respectively. The outer edges of the box are the 25th and 75th
percentiles. The whiskers extend to the minimum and maximum values. Ncells from left to right are 79, 106, 104, 30 and 57.
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We aimed to develop a more viable approach for targeting
non-repetitive regions in live cells. First, we stably expressed
dCas9-mCherry in RPE1, HeLa, U2OS and observed recruitment
of dCas9 and MCP to locus #1 in these cell lines (Supplementary
Fig. 3). We tested the efficiency of dCas9 imaging to stable
dCas9-GFP U2OS cells7 when the sgRNA was targeted to the
satellite repeat region at centromeres. Plasmid transfection or
lentiviral transduction resulted in bright nuclear spots in 60%
and 87% of the cells, respectively (Ncells¼ 500, Supplementary
Movie 1). However, for the less repetitive MUC4 locus, lentivirus
transduction resulted in discernible nuclear spots within 53% of
observed cells (Ncells¼ 260, Supplementary Movie 2), whereas
plasmid transfection yielded discernable spots in only 5% of the
cells. We also generated a stable U2OS cell line co-expressing
both dCas9-GFP and MCP-mCherry (Supplementary Fig. 4a).
We targeted the centromeric satellite repeats in this cell-line, and
observed both GFP and mCherry spots in 20% of the cells
(Ncells¼ 500). All of the GFP and YFP spots colocalized with each
other in the nucleus (Supplementary Fig. 4b).
On the basis of these results, we attempted to detect a
non-repetitive genomic site in the stable dCas9-GFP-MCP-
mCherry U2OS cell line using lentiviral transduction of sgRNA
14 -MS2s targeting the same locus. We designed 30 different
sgRNA 14 -MS2s that targeted a non-repetitive 5 kb region in
the first intron of the MUC4 gene7. Because co-transduction of
the cells with these 30 sgRNAs failed to yield any discernable
nuclear spots, we re-engineered sgRNA 2.0 with an additional
14 -MS2 extension at its 30 end (sgRNA 2.0 16 -MS2, Fig. 4a).
In this case, we were able to detect the colocalization of GFP and
mCherry spots in the nucleus using confocal microscopy
(Ncells¼ 12, Fig. 4b). However, when the cells were transduced
with only 8 of these sgRNA 2.0-16xMS2s, we only observed
the mCherry spots, while the GFP spots were no longer
detectable (Ncells¼ 11, Fig. 4b). Conversely, the mCherry spots
were not detectable in cells transduced with 8 sgRNA2.0
2 -MS2s, demonstrating that extension of sgRNA 2.0 with
additional MS2 binding sites reduces the number of sgRNAs
needed for accurate detection of a single genomic locus.
We next attempted to determine the minimum number of
sgRNAs necessary to detect a non-repetitive locus. Although cells
transduced with eight sgRNAs show detectable nuclear spots in a
confocal microscope, we were not able to detect nuclear mCherry
spots in cells transduced with four unique sgRNA 2.0 16 -MS2
targeting MUC4. However, when we imaged these cells
using LLSM35, which has superior light collection sensitivity
and lower photobleaching compared to confocal microscopy
(Supplementary Fig. 5; Supplementary Movie 3), 19 out of 52 cells
showed bright nuclear mCherry spots (2.2±0.3 spots per cell,
mean±s.e.m.). As a control, we verified that spots were not
visible when cells were mock-transfected in the absence of these
sgRNAs (Fig. 4c,d; Supplementary Movie 4). Thus, extension of
the sgRNA 2.0 combined with state-of-the-art imaging tools
enabled detection of non-repetitive regions in the genome using
as few as four unique sgRNAs.
Long-term imaging of chromatin dynamics. The bright
fluorescence signal observed at endogenous genomic using the
extended sgRNAs enabled us to monitor chromatin dynamics
throughout the cell cycle in single cells. First, we performed time
lapse imaging of dCas9-GFP targeted to locus #1 in a Hela cell
(Supplementary Movie 5). Three bright foci were observed in
the nucleus of the cells that were in the G1-S phase. As the
cells approached mitosis, each dCas9-GFP spot split into two
closely spaced spots (1.2±0.1 mm, mean±s.e.m., N¼ 3, Fig. 5a),
presumably resulting from the replication of sister chromatids.
Interestingly, the three spots were duplicated 30–60min apart
from each other, suggesting that homologous genomic loci are
replicated at different time points in different chromosomes
(Fig. 5a). Mean squared displacement (MSD) analysis revealed
that locus #1 undergoes confined diffusion (a¼ 0.38±0.03,
±95% confidence interval, Ncells¼ 42, see Methods) with a
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Figure 2 | Multicolour imaging of low-repeat-containing loci using a single CRISPR-Cas9 system. (a) Cells that are co-transfected with conventional
sgRNA and sgRNA 14 -MS2 targeting separate genomic loci are expected to recruit dCas9-mCherry to both loci while MCP–YFP localizes exclusively
to the locus targeted by the extended sgRNA. (b) Representative images of HeLa cells co-transfected with dCas9-mCherry, MCP–YFP and conventional
and extended sgRNAs targeting separate loci. The merged images show colocalization of YFP and mCherry spots (yellow) along with non-overlapping
mCherry spots (red arrows) under three different combinatorial targeting conditions. The nuclear periphery is shown in white in merged images.
(c) The number of colocalized and non-colocalized mCherry and YFP spots per cell. The dot within the boxplot represents the mean. The outer edges
of the box are the 25th and 75th percentiles. The whiskers extend to the minimum and maximum values. In total, 27 mCherry only and 49 colocalized
mCherry-YFP spots were observed in 13 cells.
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diffusion constant (D) of 4.1±0.1 10 3 mm2 s 1 (±95%
confidence interval, Fig. 5b,c; Supplementary Movie 6). Similar
results were obtained for dCas9 spots targeting telomeres and
MUC4 (Supplementary Fig. 6a,b)7.
We further investigated the binding stability of dCas9-sgRNA
to its target locus using fluorescence recovery after photobleach-
ing (FRAP). Recovery of the fluorescence signal was recorded
using HiLo microscopy36. For dCas9-sgRNA complexes targeting
telomeres, 80% of the bleached spots (Ncells¼ 83) did not show
any appreciable recovery within a 3-hour time span. The
remainder of bleached spots displayed partial recovery with a
lifetime of B3 s (Fig. 5d,e; Supplementary Movies 7–9). Similar
results were obtained for locus #1 and MUC4 (Supplementary
Fig. 6c,d). The spots that exhibited partial recovery may
constitute a population of complexes bound to off-target sites,
since the mismatches between the sgRNA and the targeted locus
are known to reduce the binding stability of Cas9 (ref. 37),
resulting in a dynamic exchange between DNA-bound and
free dCas9 within the nucleus. Contrary to a recent study that
reported a single recovery rate of 12min for dCas9 targeting
telomeres and centromeres28, we show that most dCas9-sgRNA
complexes stably bind to their genomic targets in vivo38.
Nuclear positions of LADs and non-LADs. To further test the
applicability of our dCas9 imaging platform for visualizing
distinct chromatin loci, we studied the spatial organization of
transcriptionally active as well as inactive sites associated with
nuclear lamina. The LADs are stable heterochromatin genomic
regions marked with repressive epigenetic marks39. These
domains reside at distinct positions within the nucleus3,40 by
forming large-scale ‘topological domains’41 that are conserved
features amongst many different cell types1. Previous studies
using FISH experiments have shown that LADs are preferentially
located near the nuclear lamina, while non-LADs reside primarily
within the interior of the nucleus39,42. While these fixed-cell
experiments have provided considerable insight into the relative
intranuclear positioning of these domains discerning the
spatiotemporal dynamics of these sites in live cells has
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Figure 3 | Combinatorial set of CRISPR-derived chromatin-imaging tools. (a) Schematics show engineered sgRNAs with various MS2 and PP7 motifs.
(b,c) ChIP–qPCR results show enrichment of Flag-tagged dCas9 (b), and HA-tagged MCP– or PCP–YFP (c) at the targeted loci when guided by the
conventional and engineered sgRNAs. N¼ 3 independent experiments. Error bars represent s.e.m. (d) Representative images show colocalization of dCas9
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remained a considerable technical challenge. To identify suitable
targets for our imaging platform, we searched for tandem repeat-
containing genomic hotspots that overlapped with previously
identified constitutive LAD domains39. Next, we selected 3 LADs
and 4 non-LAD genomic loci to target with the extended sgRNAs
in U2OS cells (Fig. 1b and Supplementary Fig. 7). Chromatin
state maps of U20S cells showed that the LAD sequences we
target are within a region with high Histone H3 Lysine 9 tri-
methylation (H3K9me3) marks, which are associated with stably
repressed heterochromatin regions. In contrast, the non-LAD
regions are either within or in close proximity to the coding
region of a gene marked with high H3 Lysine 36 tri-methylation
(H3K36me3), which are associated with active transcriptional
elongation (Supplementary Fig. 8). To analyse the relative
positioning of the LAD foci, we measured the distance of each
fluorescent spot to the nuclear periphery and normalized this
distance to the diameter of the nucleus (Fig. 6a; Supplementary
Fig. 7). Consistent with a previous report39, fluorescent spots
from sgRNAs that target LAD domains were located significantly
closer (t-test, Po0.001) to the nuclear envelope than the non-
LAD targeting sgRNAs (Fig. 6b). These results demonstrate the
applicability of our approach to study the 3D nuclear
organization of specific genomic sites in live cells.
Discussion
Our imaging platform based on re-engineering the sgRNAs
of the CRISPR-Cas9 system from S. pyogenes allowed us to
image genomic loci with low- or non-repetitive regions with a
minimal number of unique targeting sequences. Furthermore,
we simultaneously tracked multiple endogenous loci by using the
single CRISPR-Cas9 system. By utilizing these flexible sets of
chromatin imaging tools separately as well in a combinatorial
fashion, we were able to monitor the position and dynamics of
distinct chromatin regions. We anticipate that CRISPR-based
imaging will simplify future efforts to reveal the dynamic nature
of long-range interactions between regulatory genomic regions,
such as promoter-enhancer interactions43.
Current CRISPR imaging technologies require tandem
targeting of multiple sgRNAs to endogenous loci28,44. However,
our approach possesses several unique advantages over recent
studies that achieved multicolour chromatin imaging using
CRISPR-Cas9 by demonstrating that our method is not mainly
limited to imaging highly repetitive regions within the genome.
By increasing the copy number of the MS2 sites within a
single sgRNA, we substantially improved the fluorescent
signal per dCas9-sgRNA complex and detected as few as eight
repeat-containing loci using a single sgRNA. Therefore, our
methodology potentially enables multicolour imaging of
thousands of distinct low-repeat-containing loci within the
human genome as well as in other model organisms using a
single sgRNA.
Remarkably, the extended sgRNA 2.0 16 -MS2 design
enabled detection of non-repetitive loci with only four unique
sgRNAs using LLSM, compared to the 26 sgRNAs reported in
previous studies7. While it is possible to further reduce the
number of sgRNAs required to robustly image a non-repetitive
locus, we note that efforts to increase the imaging sensitivity need
to be weighed against the potential loss of dCas9 targeting
specificity likely to result from significant sgRNA modification.
A whole-genome dCas9 mapping studies have revealed a wide
range of off-target binding activities exhibited by the CRIPSR-
Cas9 system, thus raising an additional technical challenge45,46.
As a result, multiple sgRNAs must be targeted to the same
genomic locus in order to form a significantly brighter spot than
off-target binding sites and minimize false-positive fluorescent
readouts. Future studies will be required to increase the specificity
and efficiency of sgRNA targeting by engineering dCas9 variants
with reduced off target affinity. Sensitivity in fluorescence
imaging of dCas9-sgRNA spots can also be further improved
using split fluorescent proteins47 and novel protein labelling
approaches48. Despite these future challenges, we expect that
our extended sgRNA-dCas9 imaging method will serve as an
important step towards directly visualizing dynamics of single
genomic loci at high spatiotemporal resolution.
Methods
Plasmid construction. S. pyogenes Cas9 gene carrying D10A and H840A
mutations (dCas9) was fused to 2x SV40 nuclear localization sequence (NLS) and
3 -Flag-tag at the N terminus and with mCherry or GFP at the C terminus.
dCas9 constructs were cloned into a lentiviral vector containing an inducible
promoter pTRE3G (Tet-on 3G inducible expression system, Clontech). MCP and
PCP were fused with an HA-tag and the SV40 NLS at the N terminus and with YFP
or GFP at the C terminus. For imaging of non-repetitive loci, MCP-mCherry was
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dCas9-GFP and MCP-mCherry were transduced with 8 and 30 unique
sgRNAs targeting the non-repetitive region in the MUC4 gene. Confocal
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sgRNAs, but the dCas9-GFP spots were not detectable with eight sgRNAs.
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cells expressing dCas9-GFP and MCP-mCherry were transduced with no
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targeting telomeres. mCherry fluorescence was detected using lattice-light
sheet microscopy. Bright spots in the nucleus were observed with 1-4
sgRNAs (yellow arrows) and sgRNA telomere, but not in the absence of an
sgRNA. (d) The number of nuclear spots in cells transduced with 30, 8 and
4 sgRNAs targetingMUC4 non-repetitive region. The dot within the boxplot
represents the mean. The outer edges of the box are the 25th and 75th
percentiles. The whiskers extend to the minimum and maximum values.
Ncells from left to right are 12, 11 and 19.
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cloned into the pHR lentivirus backbone (Addgene #46911) and expressed by the
SFFV promoter.
sgRNAs with 2 -MS2, 14 -MS2, 2.0 MS2, 2.0 16 -MS2 and 2 -PP7
extensions were cloned into the pSLQ1661-sgMUC4-E3(Fþ E) (Addgene #51025)
plasmid. sgRNAs 14 -MS2 and 2.0 16 -MS2 contain A–U flip and hairpin
extension to increase targeting efficiency7. mCherry under the control of CMV
promoter was removed from the original plasmid backbone and TagBFP was
introduced into the backbone as a transduction indicator. sgRNAs were expressed
under the U6 promoter. sgRNA sequences were amplified from an oligo template
with the same 30 primer and a unique 50 primer that contain the 20 nucleotides
targeting sequence. See Supplementary Table 1 for the sequences of these primers
and oligo templates used. The sgRNA fragments and the plasmid backbone were
digested with BstXI-BamH1. The ligation was performed by controlling the molar
ratio between plasmid and the sgRNA insert 1:500 at 37 C for 15min. The ligation
solution was transformed in Stbl3 competent cells.
Cell culture. Human embryonic kidney (HEK293T), human osteosarcoma
(U2OS), retinal pigment epithelium (RPE) and human cervical cancer (HeLa) cells
were obtained from University of California Berkeley Tissue Culture Facility. No
cell lines used in this study were found in the database of commonly misidentified
cell lines that is maintained by ICLAC and NCBI Biosample. The cell lines were not
authenticated and not tested for mycoplasma contamination. The cells were
maintained in DMEM in 10% FBS (Clontech). All cells were maintained at 37 C
and 5% CO2 in a humidified incubator.
Lentiviral production and transduction. For viral production, HEK293T cells
were seeded into T75 flask 1 day before transfection. 6 mg of pMD2.G plasmid,
9 mg of psPAX plasmid and 15mg of the lentiviral vector that expresses Tet-on 3G,
dCas9 or MCP were co-transfected into HEK293T cells using FuGENE-6
(Promega) following the manufacturer’s recommended protocol. Media was
refreshed 12 h after transfection. Virus was collected 24 and 48 h after first media
refreshment, filtered through 0.45 mm filter, flash-frozen with liquid nitrogen and
stored at  80 C. For viral transduction, cells were incubated with virus solution
diluted threefold in DMEM medium and supplemented with 10mgml 1
polybrene for 24 h. The transduction efficiency was verified with BFP
fluorescence using Zeiss AxioObserver epi-fluorescent microscope. To make a
stable cell line, cells were transduced with lentivirus, selected with appropriate
antibiotics (4–6 mgml l puromycin or blasticidin) for 3 days and sorted with
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Figure 5 | Long-term tracking of specific genomic loci in live cells. (a) Snapshots of a 4 h long movie of a HeLa cell co-transfected with dCas9-mCherry,
MCP–YFP and sgRNA 14 -MS2 targeting locus #1. dCas9-sgRNA (yellow spots) remains stably bound to its targeted site throughout the cell cycle. dCas9
spots marked with a single arrow split into two closely spaced loci (double arrows) in different frames. (b) A representative image of dCas9-GFP
localization to locus #1 in U2OS cells is shown on the left. The nuclear periphery is shown in white. The 2D trajectory of the spot marked with a green
ellipse shown on the right. (c) MSD plot of dCas9-GFP spots targeting locus #1. The green curve represents a fit to a 2D random walk with a time exponent
a (Ncells¼42). (d) Representative images show partial recovery (top) and no recovery (bottom) of dCas9-GFP spots targeted to telomeres in U2OS cells
after photobleaching. (e) Fluorescence recovery of dCas9-GFP spots targeting telomeres in U2OS cells. A single exponential fit (green curve) to the
fluorescence recovery signal (red curve) reveals the lifetime (t) of the dCas9 recovery (±95% confidence interval, Ncells¼ 30).
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fluorescence-activated cell sorting (FACS). The medium containing dead cells were
replaced every day. See Supplementary Tables 2–4 for the lists of the plasmids,
sgRNAs, lentiviruses and stable cell lines used in this study.
Plasmid transfections. Cells were plated on 35mm diameter glass bottom
MatTek plates. dCas9-GFP was expressed under the Tet-on promoter in the
absence of doxycycline treatment. For regular cell lines, the ratio of plasmids
containing dCas9-mCherry and sgRNA (0.25 mg dCas9-mCherry, 2.5 mg sgRNA)
was adjusted to obtain minimum background and to enhance the dCas9-sgRNA
assembly27. Cells were imaged 24 h following transfection.
ChIP assay. HeLa cells were plated on three 10-cm plates and transfected with the
plasmids that express dCas9, MCP and sgRNA. Transfected cells were cross-linked
with 1% formaldehyde for 10min and neutralized with 125mM glycine for 5min
at 37 C. Pellets were lysed in SDS lysis buffer and incubated for 20min on ice. The
chromatin was sonicated using Branson digital sonifier for 9min at 40% amplitude
with 0.7 s ‘on’ and 1.3 s ‘off’ pulse cycles. Fragmented chromatin was diluted with
ChIP-dilution buffer (16.7mM Tris-HCl pH 8.1, 0.01% SDS, 1.1% Triton X-100
and 1.2mM EDTA) and incubated with 1.5 mg HA-Chip grade antibody (Abcam,
#9110) overnight at 4 C. After overnight incubation, 30 ml mixture of protein A-G
magnetic beads (Dynabeads, Life Technologies) was added to lysates and rotated
for 2 h at 4 C. Next, beads were washed twice on the magnetic field with low-salt
immune complex wash buffer (20mM Tris-HCl pH 8.1, 0.1% SDS, 1% Triton
X-100, 2mM EDTA, and 150mM NaCl); LiCl wash buffer (10mM Tris-HCl pH
8.1, 250mM LiCl, 1% NP40, 1% deoxycholate and 1mM EDTA); and TE (10mM
Tris-HCl pH 8.0 and 1mM EDTA). The chromatin was recovered from the beads
by 30min incubation with elution buffer (100mM NaHCO3 pH 8.0, 0.2% SDS and
5mM DTT) at 65 C (refs 49,50). After reverse cross-linking, proteinase K and
RNase digestion, DNA was extracted with ethanol precipitation and quantified via
Qubit Fluorimeter. The relative enrichment levels of genomic regions of interest
within the ChIP-DNA were assessed by qPCR amplification with specific primers
that were designed to amplify B100 bp around the sgRNA targeting sites.
Computational identification of hotspots in human genome. Regions that
contain four or more identical sgRNA target sites that are not present anywhere
else in the genome were defined as ‘genomic hotspots’. All 20-nucleotide-long
sequences ending with a PAM sequence (NGG) at the 30-end were initially
identified from the human genome (hg19). Sequences with GC content lower than
35% or higher than 80% were excluded from the analysis. Among these sgRNA
targetable genomic sites, the exact matching sequences across different chromo-
somes and sequences with less than four repeats in genome were excluded from the
analysis. The remaining sequences were sorted and distances between the adjacent
sequences were calculated using the BEDTools suite. The sequences that are
separated by more than 10 kb were removed from the analysis. The identical
20-nucleotide sgRNA-target sequences that are present within a maximum of 10 kb
genomic distance to each other were analysed for the number of repeats.
Microscopy. Confocal imaging was performed using Zeiss LSM 710 confocal
microscopy with a  63 1.4 numerical aperture (NA) oil immersion objective at
37 C with 5% CO2. 405, 488 and 561 nm excitation beams were used to image
DAPI, YFP-GFP and mCherry, respectively. To minimize the bleed through of
fluorescent signal from YFP-GFP to mCherry channels, time sharing between 488
and 561 nm excitation and image collection was used. Digital gain and offset
adjustment on PMT are optimized to use the full dynamic range of the detector.
The z sectioning step was set to 0.64mM and the range of sectioning was adjusted
manually. The z-stacks were converted to 2D projections in Image J.
For single particle tracking assays, cells were imaged using a custom-built HiLo
microscope, equipped with Nikon TiE microscope body,  100 1.49 NA oil
objective, Nikon perfect focusing system, electron-multiplied charge coupled device
(EM-CCD camera (Andor) and 405, 488 and 561 nm lasers (Coherent). The power
of 488 and 561 beams were 160 and 53Wcm 2 for GFP and mCherry excitation,
respectively. Sample heater was used to maintain the culture temperature at 37 C.
The frame rate of imaging was set to 10Hz. The movies were analysed in ImageJ.
A custom-built LLSM based on the previously described instrument design35
was used. Briefly, the light sheet was generated from the interference of an array of
30 beams in a square lattice, and dithered to create a uniform excitation sheet. The
inner and outer numerical apertures of the excitation sheet were 0.505 and 0.60,
respectively. The cells were plated on 5-mm diameter coverslips and media was
replaced with PBS before imaging. The coverslips were sonicated three times with
57% ethanol and 10% sodium hydroxide, then washed with distilled water. The
coverslips were then sterilized with ultraviolet for 30min, coated with 1% weight
per volume polylysine solution for 2–24 h and washed with cell culture medium
before usage. The sample was excited with 500 mW 488 nm beam and 100 mW
590 nm beam for GFP and mCherry imaging, respectively. The laser power was
measured at the back aperture of the objective. The sample was scanned in the
z axis of the imaging objective with a slice interval of 200 nm over a 20 mm range.
Movies were acquired at 100ms per slice using a pair of Andor iXon Ultra 897
EMCCDs for dual-colour imaging. Three-dimensional projection of the acquired
movies was generated using maximum intensity in ImageJ.
FRAP assay. Cells were imaged using the custom-built HiLo microscope equipped
with a piezo-scanning mirror (Physik Instrumente) to steer a focused 488 nm laser
beam in the image plane. Optical pathways of excitation and photobleaching beam
were controlled separately by Uniblitz shutters using custom software written in
Labview. Fluorescence spots were detected using 160Wcm 2 HiLo excitation and
photobleached by 0.7MWcm 2 focused laser beam. Time lapse of 1min between
frames was used to minimize photobleaching of the fluorescent spots during a slow
recovery. The integrated intensity of chromosome loci was calculated with the
Time Series Analyzer plugin of ImageJ and corrected for the changes in the
background fluorescence. The calculated intensity was analysed with MATLAB.
The fluorescence intensity of each spot that shows FRAP recovery was normalized
before taking their average. The recovery rate was calculated using the easyFRAP
software51.
Data analysis. Individual dCas9-GFP or -mCherry spots were imaged using the
HiLo microscopy at 30Hz frame rate and 200 kW cm 2 excitation power. The
fluorescent spots in live cells were detected using a 2D Gaussian fitting algorithm
written in Python. The majority of the spots were diffraction limited with the
full-width at half maximum of 252±106 nm (mean±s.d., N¼ 1,850). On average,
1,580 photons were detected from each spot per frame. The spots with a full-width
at half maximum between 120 and 420 nm and a minimum 800 photons detected
per frame were analysed further, and the rest of the spots were excluded from data
analysis.
The position of spots was tracked by fitting their intensity profile to a 2D
Gaussian equation using the ImageJ plugin, ThunderStorm. The MSD is calculated
from the 2D particle tracking data. D was calculated by x2h i¼4Dta , where ao1
and ¼ 1 indicate confined and free diffusion, respectively. To account for the drift
of the microscope stage and cell movement in long-term tracking experiments,
only the pairwise distances between the spots have been used in the MSD
analysis52.
To evaluate the transcriptional state of the LAD and non-LAD domains
in U20S cells, we analysed ENCODE chromatin state maps for H3K9me3
(GEO: GSM788078) and H3K36me3 (GEO: GSM788076) marks.
LAD #2
3 μm
Non-LAD #7
1.0
0.8
0.6
0.4
0.2
0.0
#1 #2 #3 #4 #5 #6 #7
Locus
N
or
m
al
iz
ed
 d
ist
an
ce
LAD
***
***
***
Non-LAD
a b
LaminB BFP
dCas9 GFP
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Data availability. All relevant data are available from the authors upon request.
Chromatin state maps used in analyses are available from the GEO with accession
numbers GSM788078 and 788076.
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